Essential medicines availability in Czech Republic

AVAILABILITY OF ESSENTIAL MEDICINES
Country study: Czech Republic
Comparison of locally available products with WHO list of essential medicines
Data source: Czech State Institute for Drug Control
Data download date: December 30, 2016
Publication date: January 27, 2017
For more details contact Arete-Zoe
ARETE-ZOE, LLC: 1334 E Chandler Blvd 5A-19, 85048 Phoenix, AZ, USA | T:+1-480-409-0778 (24/7) | website: http://www.aretezoe.com/

Essential medicines by organ class
A – Alimentary tract and metabolism
B – Blood and blood forming organs
C - Cardiovascular system
D – Dermatologicals
G – Genito-urinary system and sex hormones
H – Systemic hormonal preparations, excl. sex hormones and insulins
J – Antiinfectives for systemic use
L – Antineoplastic and immunomodulating agents
M – Musculo-skeletal system
N – Nervous system
P – Antiparasitic products, insecticides and repellents
R – Respiratory system
S – Sensory organs
V – Various

Availability of essential medicines
34 30
25 21 19
11
119
45
6
37 36
10 13
2125 23 22
9 12 10
80
39
5
33
6 9 9 10
0
20
40
60
80
100
120
140
WHO Essential Medicines
Availability (number of registrations)

BREAKDOWN BY ORGAN CLASS
Essential medicines marketed and available by organ class
List of medicines unavailable locally

ALIMENTARYAND METABOLISM
Essential medicines marketed and available

Availability of essential medicines: A
0
100
200
300
400
500
600
700
Approvals (number of registrations)

8
430
2 5 7
79
05
52
2 2 3 13 0
0
50
100
150
200
250
300
350
400
450
500
ranitidine
omeprazole
atropin
hyoscinebutylbromide
metoclopramide
ondansetron
hyoscinehydrobr
A02BA02 A02BC01 A03BA01 A03BB01 A03FA01 A04AA01 A04AD01
A02 - Acid related disorders | A03 - functional GI disorders
A04 – Antiemetics, antinauseants

0
8
86
0 4 0
24
0 3
67
0 5 10
0 2 0
10
0 3
12
0
10
20
30
40
50
60
70
80
90
100
docusatesodium
sennaglycosides
lactulose
paromomycin
medicinalcharcoal
oralrehydrationsalts
loperamide
hydrocortisone
sulfasalazine
multienzymes
A06AA02 A06AB06 A06AD11 A07AA6 A07BA01 A07CA A07DA03 A07EA02 A07EC01 A09AA02
Approvals (number of
registrations)
Availability (number of
registrations)
A06 - Laxatives | A07 – Antidiarrheals | A09 – Digestives

A10 – Drugs used in diabetes | A11 – Vitamins | A12 – Mineral supplements
153
94
657
2
144
3 6 18 2 22 2 1 417 6
54
1 13 3 1 6 2 16 2 1 2
0
100
200
300
400
500
600
700
insulin,fast-acting
insulin,intermediate
metformin
glibenclamide
gliclazide
retinol
ergocalciferol
cholecalciferol
thiamine
ascorbicacid
pyridoxine
calciumgluconate
othermineralproducts
Diabetes Diabetes Diabetes Diabetes Diabetes Vitamins Vitamins Vitamins Vitamins Vitamins Vitamins Minerals Minerals
A10AB A10AC A10BA02 A10BB01 A10BB09 A11CA01 A11CC01 A11CC05 A11DA01 A11GA01 A11HA02 A12AA03 A12CX

Unavailable essential medicines: A
ATC Code Active ingredient
A04AD01 hyoscine hydrobromide
A06AA02 docusate sodium
A07AA6 paromomycin
A07CA oral rehydration salt formulations
A07EA02 hydrocortisone
A11HA01 nicotinamide
A11HA04 riboflavin
A12CB01 zinc sulfate
A12CD01 sodium fluoride

BLOOD AND BLOOD FORMING ORGANS

Availability of essential medicines: B
0
50
100
150
200
250
300
350
400
450
Available (number of registrations)

4
1
0
12
17
13
15
0
4
1
0
12
17
13
15
0
0
2
4
6
8
10
12
14
16
18
warfarin
heparin
dalteparin
enoxaparin
nadroparin
clopidogrel
acetylsalicylicacid
streptokinase
B01AA03 B01AB01 B01AB04 B01AB05 B01AB06 B01AC04 B01AC06 B01AD01
registrations)
Available (number of
registrations)
2 2 6
95
2 2 3
17
0
10
20
30
40
50
60
70
80
90
100
trenexamicacid
phytomenadione
coag.factorsIX,II,VIIand
X
coagulationfactorVIII
B02AA02 B02BA01 B02BD01 B02BD02
registrations)
registrations)
B01 – Antithrombotics | B02 – Antihemorrhagics

B03 – Antianemics
4 4
5
0
11
3 3
0
1
0
1
2
3
4
5
6
iron bivalent, oral iron trivalent, oral iron in combination
with folic acid
hydroxycobalamin folic acid
B03AA B03AB B03AD B03BA03 B03BB01
registrations)
registrations)

B05 – Blood substitutes and perfusion solutions
97
0 0 0
259
409
109
57 45
14 14 20
0
24
0 0 0
39
74
19 8 2 5 8 7 0
0
50
100
150
200
250
300
350
400
450
plateletconcentrates,
wholeblood
dextran
redbloodcells
freshfrozenplasma
carbohydratesfori.v.
nutrition
electrolytes
electrolyteswith
carbohydrates
mannitol
isotonicsolutions
potassiumchloride
sodiumbicarbonate
sodiumchloride
magnesiumsulfate
B05A B05AA05 B05AX01 B05AX03 B05BA03 B05BB01 B05BB02 B05BC01 B05DA B05XA01 B05XA02 B05XA03 B05XA05

Unavailable essential medicines: B
B01AB04 dalteparin
B01AD01 streptokinase
B03BA03 hydroxycobalamin
B05AA05 dextran
B05AX01 red blood cells
B05AX03 fresh frozen plasma
B05XA05 magnesium sulfate

CARDIOVASCULAR SYSTEM

Availability of essential medicines: C
0
50
100
150
200
250
300
350
400
450
500

2 2
28
3
15
1
13
36
2 1
8
1
8
1
7 6
0
5
10
15
20
25
30
35
40
digoxin lidocaine amiodaron dopamine epinephrine
(adrenaline)
ephedrine glyceryl trinitrate isosorbide
dinitrate
C01AA05 C01BB01 C01BD01 C01CA04 C01CA24 C01CA26 C01DA02 C01DA08
registrations)
registrations)
C01 – Cardiac therapy

1 1
35 15 1
234
36
193
253
454
3
49 51
250
1 1 15 4 1
42
21 37 20
47
2 19 19 34
0
50
100
150
200
250
300
350
400
450
500
methyldopa(levorotatory)
hydrochlorothiazide
furosemide
spironolactone
propranolol
metoprolol
atenolol
bisoprolol
carvedilol
amlodipine
nifedipine
verapamil
enalapril
simvastatin
C02 C03 C03 C03 C07 C07 C07 C07 C07 C08 C08 C08 C09 C10
registrations)
registrations)
C02 – antihypertensives
C03 – diuretics
C07 – beta-blockers
C08 – calcium channel blockers
C09 – ACEIs
C10 – lipid modifying agents

Unavailable essential medicines: C
C02DB02 hydrazaline
C02DD01 nitroprusside
C03DB01 amiloride

DERMATOLOGICALS

Availability of essential medicines: D
40
26
24 24
4
2 2 1 1 1
23
9
4
6
3
1 2
0 1 1
0
5
10
15
20
25
30
35
40
45
povidone-iodine
antipsoriaticsfortopical
use
terbinafine
betamethasone
benzoylperoxide
podophyllotoxin
carbamide
mupirocin
nystatin
hydrocortisone
D08AG02 D05A D01BA02 D07AC01 D10AE01 D06BB04 D02AE01 D06AX09 D01AA01 D07AA02

Unavailable essential medicines: D
D01AC02 miconazole
D01AE12 salicylic acid
D01AE13 selenium sulfide
D01BA01 griseofulvin
D02AB zinc products
D06BA01 silver sulfadiazine
D06AX09 muciprocin*
D08AC02 chlorhexidine
D08AE05 chloroxylenol
D08AX05 isopropanol
D08AX06 potassium permanganate
D08AX08 ethanol
* Registered, not available in Q4/2016

GENITO-URINARY SYSTEM
SEX HORMONES

Availability of essential medicines: G
50
41
19
15 15
11 9 9
5 4 4 2
13
5 7 8
5
2
8
5 4
1 1 1
0
10
20
30
40
50
60
levonorgestreland
ethinylestradiol
testosteron
progesteron
plasticIUDwithprogesteron
levonorgestrel
misoprostol
clotrimazole
levonorgestrelandestrogen
intravaginalcontraceptives
clomifene
mifepristone
medroxyprogesterone
G03AA07 G03BA03 G03DA04 G02BA03 G03AD01 G02AD06 G01AF02 G03AB03 G02BB G03GB02 G03XB01 G03AC06

Unavailable essential medicines: G
G02AB03 ergometrine
G02BA02 plastic IUD with copper
G03AA05 norethisterone and ethinylestradiol
G03AA08 medroxyprogesterone and estrogen
G03AC01 norethisterone
G03AC03 levonorgestrel
G03AC08 etonorgestrel

SYSTEMIC HORMONES
EXCL. SEX HORMONES AND INSULINS

Availability of essential medicines: H
90
58
52
25
16
2 2 2 1 1
17
2
17
6 2 2 1 1 1 1
0
10
20
30
40
50
60
70
80
90
100
levothyroxinesodium
dexamethasone
methylprednisolon
desmopressin
hydrocortisone
oxytocin
propylthiouracil
Iodinetherapy
fludrocortisone
glucagon
H03AA01 H02AB02 H02AB04 H01BA02 H02AB09 H01BB02 H03BA02 H03CA H02AA02 H04AA01

Unavailable essential medicines: H
H02AB06 prednisolone

ANTIINFECTIVES

Availability of essential medicines: J
0
50
100
150
200
250
300
350
400
J01 - Antibacterials for systemic use

12 2 12 14 12 24
1 6
372
10 9
31 25
5 97 1 4 10 3 12 1 2
24
3 5 5 5 1 2
0
50
100
150
200
250
300
350
400
doxycycline
chloramphenicol
ampicillin
amoxicillin
benzylpenicillin
phenoxymethylpenicillin
benzathinbenzylpenicilin
procainbenzylpenicilin
amoxicillinandenzyme
inh.
cefazolin
cefotaxime
ceftazidime
ceftriaxone
cefixime
imipenemandenzymeinh.
J01AA02J01BA01J01CA01J01CA04J01CE01J01CE02J01CE08J01CE09J01CR02J01DB04J01DD01J01DD02J01DD04J01DD08J01DH51
Tetracyclines
Amphenicoles
Penicillins
Other beta-lactams

3 9
168
46
17 10 9 6
47
68
28
4 1
188
1 8
22 15 8 5 3 2
11 4 6 3 1
10
0
20
40
60
80
100
120
140
160
180
200
trimethoprim
sulfamethoxazole+
trim.
clarithromycin
azithromycin
clindamycin
gentamicin
amikacin
ofloxacin
ciprofloxacin
levofloxacin
vancomycin
metronidazole
nitrofurantoin
linezolid
J01EA01 J01EE01 J01FA09 J01FA10 J01FF01 J01GB03J01GB06J01MA01J01MA02J01MA12 J01XA01 J01XD01 J01XE01 J01XX08
registrations)
registrations)
SA+T Macrolides Aminoglycosides Quinolones Other

Unavailable essential medicines: J
J01CF02 cloxacillin
J01DB01 cefalexin
J01EC02 sulfadiazine
J01FA01 erythromycin
J01GA01 streptomycin
J01GB04 kanamycin
J01XX04 spectinomycin

J04 - Antimycobacterials for systemic use
3
1 1
2
1 1
22
1 1 1 1 1 1
0
1
2
3
4
rifampicin rifabutin capreomycin isoniazid pyrazinamid ethambutol clofazimine
J04AB02 J04AB04 J04AB30 J04AC01 J04AK01 J04AK02 J04BA01
2
252
1
22
0
50
100
150
200
250
300
amphotericin B fluconazol
J02AA01 J02AC01
J02 - Antimycotics for systemic use

J02 – Antimycotics | J04 - Antimycobacterials
J02AX01 flucytosine
J04AA01 p-aminosalicylic acid*
J04AB01 cycloserine*
J04AB05 rifapentine
J04AD01 protionamide
J04AD03 ethionamide
J04AK03 terizidone
J04AK05 bedaquiline*
J04AK06 delamanid*
J04AM02 rifampicin and isoniazid
J04AM03 ethambutol and isoniazid
J04AM05 rifampicin, pyrazinamide and isoniazid
J04AM06 rifampicin, pyrazinamide, ethambutol and isoniazid
J04BA02 dapsone

J05 - Antivirals for systemic use
8
61
6
11 8
2 4
29
2
35
7
26
11 10 11
16
6
2 1 2
7
3 1 1 2 1 3 5
1 2 2 1 1 2 1 1 1 1 1 1
0
10
20
30
40
50
60
70
aciclovir
ribavirin
ritonavir(r)
atazanavir
darunavir
simeprevir
zidovudine(ZDVorAZT)
lamivudine(3TC)
abacavir(ABC)
tenofovirdisoproxil
fumarate
entecavir
efavirenz(EFVorEFZ)
oseltamivir
lamivudine+zidovudine
(ZDVorAZT)
abacavir+lamivudine
emtricitabine+tenofovir
daclatasvir
sofosbuvir
dasabuvir
ledipasvir+sofosbuvir
J05AB J05AB J05AE J05AE J05AE J05AE J05AF J05AF J05AF J05AF J05AF J05AGJ05AHJ05ARJ05ARJ05AR J05AX J05AX J05AX J05AX

J05 - Antivirals for systemic use
J05AB14 valganciclovir
J05AE01 saquinavir (SQV)*
J05AE30 lopinavir + ritonavir (LPV/r)
J05AF04 stavudine (d4T)*
J05AG01 nevirapine (NVP)*
J05AR05 lamivudine + nevirapine + zidovudin
J05AR06 efavirenz + emtricitabine + tenofovir*
J05AR07 lamivudine + nevirapine + stavudine
J05AX66 ombitasvir + paritaprevir + ritonavir

39
65
6
2
10
21
4 1
0
10
20
30
40
50
60
70
immunoglob.,
extravasc.adm.
immunoglob.,
intravas. adm.
anti-D
immunoglobulin
tetanus
immunoglobulin
J06BA01 J06BA02 J06BB01 J06BB02
registrations)
registrations)
J06 - Immune sera and immunoglobulins

J06AA01 diphtheria antitoxin
J06AA03 snake venom antiserum*
J06BB05 rabies immunoglobulin
J06 - Immune sera and immunoglobulins

J07 - Vaccines
3 2
27
1
6 8
38
2
39
19
3 6
13
29
9
24
12
80
1 1 4 1 2 1 5 1 4 5 1 2 2 2 1 1 1 4
0
10
20
30
40
50
60
70
80
90

J07AF01 diphtheria toxoid
J07AJ01 pertussis vaccine
J07AN01 tuberculosis, live attenuated
J07BD01 measles vaccine, live attenuated
J07BE01 mumps vaccine, live attenuated*
J07BJ rubella vaccines
J07 - Vaccines

ANTINEOPLASTIC AGENTS
IMMUNOMODULANTS

Availability of essential medicines: L
L01 - Antineoplastic agents
Alkylating agents Antimetabolites Plant alkaloids
Cytotoxic antibiotics
Other antineoplastic agents
598
358
4 1 3 9 1 13 1 1 3 7 6 13 16 1 2 8 7 15 15 14 1 5 11 11 2 2 2 4 1 11
0
100
200
300
400
500
600
700
cyclophosphamide
chlorambucil
ifosfamide
bendamustine
dacarbazine
methotrexate
mercaptopurine
tioguanine
fludarabine
cytarabine
fluorouracil
gemcitabine
capecitabine
vinblastine
vincristine
vinorelbine
etoposide
paclitaxel
docetaxel
doxorubicin
bleomycin
cisplatin
carboplatin
oxaliplatin
rituximab
trastuzumab
bevacizumab
imatinib
hydroxycarbamide
irinotecan
Antineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic agentsAntineoplastic ag
L01AA01L01AA02L01AA06L01AA09L01AX04L01BA01L01BB02L01BB03L01BB05L01BC01L01BC02L01BC05L01BC06L01CA01L01CA02L01CA04L01CB01L01CD01L01CD02L01DB01L01DC01L01XA01L01XA02L01XA03L01XC02L01XC03L01XC07L01XE01L01XX05L01XX19

Availability of essential medicines: L
L02 – Endocrine therapy | L03 – Immunostimulants | L03 – Immunosuppressants
12 6
204
181
100 90
17
63 56
4 2 14 19 10 3 3 11 6
0
50
100
150
200
250
leuprorelin tamoxifen bicalutamide anastrozole filgrastim peginterferon
alfa-2b*
peginterferon
alfa-2a*
ciclosporin azathioprine
Endocrine Endocrine Endocrine Endocrine Immunostim Immunostim Immunostim Immunosupp Immunosupp
L02AE02 L02BA01 L02BB03 L02BG03 L03AA02 L03AB10 L03AB11 L04AD01 L04AX01

Unavailable essential medicines: L
L01DA01 dactinomycin
L01DB02 daunorubicin
L01XB01 procarbazine
L01XX02 asparaginase*
L01XX09 miltefosine
L01XX14 tretinoin

MUSCULOSKELETAL SYSTEM

Availability of essential medicines: M
557
56
4 3 2 0
58
9 1 1 2 0
0
100
200
300
400
500
600
ibuprofen allopurinol suxamethonium atracurium penicillamine vecuronium
M01AE01 M04AA01 M03AB01 M03AC04 M01CC01 M03AC03

Unavailable essential medicines: M
M03AC03 vecuronium

NERVOUS SYSTEM

Availability of essential medicines: N
L01 - Anesthetics
0
10
1
49
79
21
7
20 3 1
11 9
3 3 0
0
10
20
30
40
50
60
70
80
90
halothane isoflurane ketamine propofol nitrous oxide bupivacaine lidocaine lidocaine,
combinations
N01AB01 N01AB06 N01AX03 N01AX10 N01AX13 N01BB01 N01BB02 N01BB52

26
88
653
41
226
5 2 2 11
90
2
73
8 9 18 11 27 3 2 1 10 33
1 11
0
100
200
300
400
500
600
700
morphine
hydromorphone
oxycodone
acetylsalicylicacid
paracetamol
phenobarbital
phenytoin
ethosuximide
carbamazepine
valproicacid
biperiden
levodopaand
decarboxylaseinhibitor
N02AA01 N02AA03 N02AA05 N02BA01 N02BE01 N03AA02 N03AB02 N03AD01 N03AF01 N03AG01 N04AA02 N04BA02
N02 – Analgesics | N03 – Anti-epileptics | N04 – Anti-Parkinsonics

N05 – Psycholeptics | N06 – Psychoanaleptics | N07 – Other
1 2 4 19
1
255
7 0
40
3 3
44
2 3 2
182
61 1 4 4 1
42
5 0 17 2 1 6 1 2 1
23
0
0
50
100
150
200
250
300
chlorpromazine
fluphenazine
haloperidol
clozapine
lithium
risperidone
diazepam
lorazepam
midazolam
clomipramin
amitriptylin
fluoxetin
caffeinecitrate
neostigmine
pyridostigmine
nicotine
methadone
N05AA01N05AB02N05AD01N05AH02N05AN01N05AX08N05BA01N05BA06N05CD08N06AA04N06AA09N06AB03N06BC01N07AA01N07AA02N07BA01N07BC02
Antipsychotics Anxiolytics Hypn. Psychoanaleptics Other Addictions

Unavailable essential medicines: N
N01AB01 halothane
N01BB52 lidocaine, combinations*
N05BA06 lorazepam
N07BC02 methadone*

ANTIPARASITICS, INSECTICIDES
REPELLENTS

Availability of essential medicines: P
P01 – Antiprotozoals | P02 – Anthelmintics | P03 – Ectoparasiticides
7
1 1 1 1 1 1 1 11 1 1 1 1 1
0 0 0
0
1
2
3
4
5
6
7
8
permethrin
metronidazole
hydroxychloroquine
primaquine
quinine
mebendazole
meglumineantimoniate
pentamidineisethionate
praziquantel
Ectoparasites Antiprotozoals Antiprotozoals Antiprotozoals Antiprotozoals Anthelmintics Antiprotozoals Antiprotozoals Anthelmintics
P03AC04 P01AB01 P01BA02 P01BA03 P01BC01 P02CA01 P01CB01 P01CX01 P02BA01

Unavailable essential medicines: P
P01CB01 meglumine antimoniate*
P01CX01 pentamidine isethionate*
P01AC01 diloxanide
P01BA01 chloroquine
P01BA06 amodiaquine
P01BB01 proguanil
P01BC02 mefloquine
P01BD01 pyrimethamine
P01BD51 pyrimethamine, comb.
P01BE02 artemether
P01 – Antiprotozoals
P01BE03 artesunate
P01BF01 artemether and lumefantrine
P01BF02 artesunate and mefloquine
P01BF03 artesunate and amodiaquine
P01CA02 benznidazole
P01CB02 sodium stibogluconate
P01CC01 nifurtimox
P01CD01 melarsoprol
P01CX02 suramin sodium
P01CX03 eflornithine

Unavailable essential medicines: P
P02BA01 praziquantel*
P02BA02 oxamniquine
P02BX04 triclabendazole
P02CA03 albendazole
P02CB02 diethylcarbamazine
P02CC01 pyrantel
P02CE01 levamisole
P02CF01 ivermectin
P02DA01 niclosamide
P03AX01 benzyl benzoate
P02 – Anthelmintics | P03 - Ectoparasiticides

RESPIRATORY SYSTEM

Availability of essential medicines: R
45
32
7 6 5 5 4 3 2 0
17 17
4 5 4 3 2 2 1 0
0
5
10
15
20
25
30
35
40
45
50
loratadine
xylometazolinr
beclometasone
salbutamol
budesonide
salbutamol
codeine
ipratropiumbromide
lungsurfactants
cyclizine
R06AX13 R01AA07 R03BA01 R03AC02 R01AD05 R03CC02 R05DA04 R03BB01 R07AA R06AE03

Unavailable essential medicines: R
R06AE03 cyclizine

SENSORY ORGANS

Availability of essential medicines: S
1 1 1 1
19
45
1 3 11 1 1 1
11
16
1 1 1
0
5
10
15
20
25
30
35
40
45
50
gentamicin aciclovir prednisolone acetazolamide timolol latanoprost atropine tropicamide fluorescein
S01AA11 S01AD03 S01BA04 S01EC01 S01ED01 S01EE01 S01FA01 S01FA06 S01JA01

Unavailable essential medicines: S
S01AA09 tetracycline
S01EA01 epinephrine
S01EB01 pilocarpine
S01HA03 tetracaine

VARIOUS

Availability of essential medicines: V
545
61 24 34 3 2 1 1 1 1 3 1
57 20 9 6 2 1 1 1 1 1 0 0
0
100
200
300
400
500
600
oxygen
waterforInjection
iohexol
calciumfolinate
bariumsulfatewith
suspendingagents
deferoxamine
protamine
naloxone
potassiumferric
hexacyanoferrate(II)
·2H2O(Prussian
blue)
mesna
methylthioninium
chloride(methylene
blue)
thiosulfate
V03AN01 V07AB V08AB02 V03AF03 V08BA01 V03AC01 V03AB14 V03AB15 V03AB31 V03AF01 V03AB17 V03AB06

Unavailable essential medicines: V
V03AB03 edetates
V03AB06 thiosulfate*
V03AB08 sodium nitrite
V03AB09 dimercaprol
V03AB17 methylthioninium chloride (methylene blue)*
V03AB23 acetylcysteine
V03AB34 fomepizole
V03 – All other therapeutic products

Unavailable essential medicines: V
V04CF01 tuberculin, purified protein derivative (PPD) - BCG
V07AV technical disinfectants
V08AA01 diatrizoic acid
V08AC02 iotroxic acid
V04 – Diagnostic agents | V07 – Other non-therapeutic products | V08 – Contrast media

ARETE-ZOE, as a consultancy, provides solutions to complex problems in the
high stakes and high consequence environment of Global Pharmaceuticals,
including clinical research, healthcare informatics, and public
health. We blend established, Pharma sector methodologies, innovation, and
adaptations/transfers from other sectors to identify and resolve consequential
practices that pose risk and often result in avoidable patient casualty. However,
we are specifically, not a patient advocacy group but believe in optimizing
organizational effectiveness and that smart business is agile, competitive and
profitable, while intrinsically safe, secure, and resilient. We work within a global
context because transnational interests influence national circumstances and
choices at point of prescription.
ARETE-ZOE, provides full spectrum organizational and operational risk
management consultancy. Our published materials provide a glimpse of some
aspects of our services to demonstrate both knowledge and ongoing participation
within the Pharmaceutical Industry. Our analysis and consultancy includes all
channels of misuse, diversion, counterfeiting and illicit exploitation of
pharmaceuticals, medical devices, and precursor chemicals. Our advisement is to
manufactures, jurisdictional entities, insurers, legislators, litigators, patients, and
health care providers.

This scope also frequently segues into the nexus of crime and terrorism as
significant influencers that undermine sector integrity differentiated from other
criminal activity. Obviously, vulnerability assessment, information collection
management and intelligence production supporting decision-making for risk
reduction and interventions are routinely within the scope of our services as well
as design and implementation of operational control measures.

Essential medicines availability in Czech Republic

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (12)

More from Arete-Zoe, LLC

More from Arete-Zoe, LLC (20)

Recently uploaded

Recently uploaded (20)

Essential medicines availability in Czech Republic